These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 27078017

  • 1. Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF.
    Bhattacharyya S, Feferman L, Tobacman JK.
    PLoS One; 2016; 11(4):e0153463. PubMed ID: 27078017
    [Abstract] [Full Text] [Related]

  • 2. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
    Bhattacharyya S, Feferman L, Han X, Ouyang Y, Zhang F, Linhardt RJ, Tobacman JK.
    J Biol Chem; 2018 Jul 13; 293(28):11076-11087. PubMed ID: 29794138
    [Abstract] [Full Text] [Related]

  • 3. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells.
    Bhattacharyya S, Feferman L, Terai K, Dudek AZ, Tobacman JK.
    Oncotarget; 2017 Jan 17; 8(3):4169-4180. PubMed ID: 27926479
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.
    Bhattacharyya S, Feferman L, Tobacman JK.
    J Biol Chem; 2014 Jun 20; 289(25):17564-75. PubMed ID: 24778176
    [Abstract] [Full Text] [Related]

  • 5. Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.
    Bhattacharyya S, Feferman L, Tobacman JK.
    Biochim Biophys Acta; 2015 Mar 20; 1849(3):342-52. PubMed ID: 25511584
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia.
    Bhattacharyya S, Tobacman JK.
    PLoS One; 2012 Mar 20; 7(3):e33250. PubMed ID: 22428001
    [Abstract] [Full Text] [Related]

  • 7. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling.
    Bhattacharyya S, O-Sullivan I, Tu J, Chen Z, Tobacman JK.
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan 20; 1870(1):166913. PubMed ID: 37813168
    [Abstract] [Full Text] [Related]

  • 8. Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects.
    Bhattacharyya S, Feferman L, Tobacman JK.
    Oncogene; 2014 Nov 20; 33(47):5467-76. PubMed ID: 24240681
    [Abstract] [Full Text] [Related]

  • 9. N-Acetylgalactosamine-4-sulfatase (Arylsulfatase B) Regulates PD-L1 Expression in Melanoma by an HDAC3-Mediated Epigenetic Mechanism.
    Bhattacharyya S, O-Sullivan I, Tobacman JK.
    Int J Mol Sci; 2024 May 28; 25(11):. PubMed ID: 38892038
    [Abstract] [Full Text] [Related]

  • 10. Increased GPNMB, phospho-ERK1/2, and MMP-9 in cystic fibrosis in association with reduced arylsulfatase B.
    Bhattacharyya S, Feferman L, Sharma G, Tobacman JK.
    Mol Genet Metab; 2018 Jun 28; 124(2):168-175. PubMed ID: 29703589
    [Abstract] [Full Text] [Related]

  • 11. Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases.
    Tobacman JK, Bhattacharyya S.
    Int J Mol Sci; 2022 Oct 29; 23(21):. PubMed ID: 36361933
    [Abstract] [Full Text] [Related]

  • 12. SARS-CoV-2 spike protein-ACE2 interaction increases carbohydrate sulfotransferases and reduces N-acetylgalactosamine-4-sulfatase by p38 MAPK.
    Bhattacharyya S, Tobacman JK.
    Signal Transduct Target Ther; 2024 Feb 14; 9(1):39. PubMed ID: 38355690
    [Abstract] [Full Text] [Related]

  • 13. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.
    Kotlo K, Bhattacharyya S, Yang B, Feferman L, Tejaskumar S, Linhardt R, Danziger R, Tobacman JK.
    Glycoconj J; 2013 Oct 14; 30(7):667-76. PubMed ID: 23385884
    [Abstract] [Full Text] [Related]

  • 14. Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity.
    Bhattacharyya S, Feferman L, Han X, Xia K, Zhang F, Linhardt RJ, Tobacman JK.
    Oncotarget; 2020 Jun 16; 11(24):2327-2344. PubMed ID: 32595831
    [Abstract] [Full Text] [Related]

  • 15. Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3).
    Bhattacharyya S, Feferman L, Tobacman JK.
    Oncotarget; 2017 Nov 21; 8(59):100242-100260. PubMed ID: 29245974
    [Abstract] [Full Text] [Related]

  • 16. Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B.
    Bhattacharyya S, Tobacman JK.
    J Nutr Biochem; 2012 Sep 21; 23(9):1058-63. PubMed ID: 22079206
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB.
    Ripoll VM, Meadows NA, Raggatt LJ, Chang MK, Pettit AR, Cassady AI, Hume DA.
    Gene; 2008 Apr 30; 413(1-2):32-41. PubMed ID: 18313864
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Restriction of Aerobic Metabolism by Acquired or Innate Arylsulfatase B Deficiency: A New Approach to the Warburg Effect.
    Bhattacharyya S, Feferman L, Tobacman JK.
    Sci Rep; 2016 Sep 08; 6():32885. PubMed ID: 27605497
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.